4篇
您的检索式：作者名="Fengxia Hou"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Will Rubber Market Keep the Rising Trend This Year?显示文摘After continuous downturn for the past few years,the rubber material market finally revived in 2016.The price of NR rose from about RMB 10,000 Yuan(per ton,similarly hereinafter)at the beginning of 2016 to RMB20,000 Yuan at the end of the year,which moved ahead with fluctuation all over the year.In 2017,the | Hou Fengxia | 2017 | 中国橡胶2017，33，8： | 0 |
| 2 | Rubber Material Industry Must Reduce Capacity and Speculation to Pull Through显示文摘Global rubber price is continuously low and the manufacturing and trading enterprises are in a dilemma,how to develop in future becomes a sore point of rubber material enterprises.On November 6,China Rubber Industry Association(hereinafter referred to as CRIA)Rubber Material Division and Guosen Futures Co.,Ltd.jointly held'2015 China Rubber Material Market Forum and Rubber Industry Roundtable'in Xishuangbanna,over 120 persons from natural | Hou Fengxia Chu Fangxu | 2015 | 中国橡胶2015，31，24： | 0 |
| 3 | Discussions about How to Respond to Market Downturn in Rubber Materials Industry显示文摘On August 26,CRIA Rubber Materials Professional Committee held the'2016 Rubber Materials Market Forum&General Meeting of CRIA Rubber Materials Professional Committee'in Kunming.The present representatives made in-depth discussions about the focus issues in front of the rubber materials industry,including sluggish market demand,low price,surging import | Hou Fengxia | 2016 | 中国橡胶2016，32，20： | 0 |
| 4 | Incidence of Major Adverse Cardiovascular and Cerebrovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention with Iodixanol: An Observational Postauthorization Study显示文摘Objective:This study aimed to evaluate the major adverse cardiovascular and cerebrovascular events(MACCEs)and overall safety profile associated with iodixanol in Chinese patients undergoing percutaneous coronary intervention(PCI).Methods:Patients at 30 centers in China registered in the OpenClinic v3.6 database from October 30,2013,to October 7,2015,were included in the study.The primary endpoint was in-hospital MACCEs including target lesion revascularization(TLR),stroke,stent thrombosis,cardiac death,and PCI-related myocardial infarction(MI)within 72 h post-PCI.Secondary endpoints were MACCEs from 72 h to 30 d post-PCI and other safety events within 30 d post-PCI.Results:A total of 3,042 patients were enrolled.The incidence of MACCEs within 72 h post-PCI was 2.33%(n=71),including cardiac death(0.03%,n=1)and PCI-related MI(2.30%,n=70).The incidence of MACCEs from 72 h to 30 d post-PCI was 0.16%(n=5),including cardiac death(0.10%,n=3),PCI-related MI(0.03%,n=1),and TLR for stent thrombosis(0.03%,n=1).The incidence of composite angiographic or procedural complications was 2.86%(n=87);233(7.86%)patients had results suggesting contrast-induced acute kidney injury.Conclusions:These findings indicate that the use of iodixanol in Chinese patients undergoing PCI is associated with a low incidence of MACCEs,confirming its safety in this population. | Xiaozeng Wang Dengfeng Ma Tianchang Li Bao Li Xi Su Yanqing Wu Zhimin Du Zheng Ji Ping Yang Baisong Yang Xuebin Cao Junxia Li Fengxia Hou Ziping Cheng Banglong Xu Yaling Han | 2023 | Cardiology Discovery2023，3，2： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员